News
StockStory.org on MSN1d
BIIB Q1 Earnings Call: New Product Growth Outpaces Declining MS Franchise Amid Lowered GuidanceBiotech company Biogen (NASDAQ:BIIB) in Q1 CY2025, with sales up 6.1% year on year to $2.43 billion. Its non-GAAP profit of ...
We recently published a list of 15 Small-Cap Healthcare Stocks Hedge Funds Are Buying. In this article, we are going to take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback